Patient Outcomes

$305,247P01FY2000CANIH

University Of Texas Md Anderson Can Ctr, Houston TX

Investigators

Linked publications & trials

Paper 37217238 Paper 33407351 Paper 32665395 Paper 31639288 Paper 29276057 Paper 29051679 Paper 28870103 Paper 28395117 Paper 27251077 Paper 26929242 Paper 26617681 Paper 26552330 Paper 26499452 Paper 26026733 Paper 25962157 Paper 25919612 Paper 25210770 Paper 24962422 Paper 24924773 Paper 24718136 Paper 24436157 Paper 24412268 Paper 24137052 Paper 23934001 Paper 23888090 Paper 23415144 Paper 23301387 Paper 23300005 Paper 23133398 Paper 22559693 Paper 22340639 Paper 22340637 Paper 21944317 Paper 21642388 Paper 21258497 Paper 20830707 Paper 20729976 Paper 19508236 Paper 19123662 Paper 18843032 Paper 18820540 Paper 18369302 Paper 18315387 Paper 18165387 Paper 17908588 Paper 17908587 Paper 17889285 Paper 17868784 Paper 17825885 Paper 17825882 Paper 17825399 Paper 17825396 Paper 17825391 Paper 17825389 Paper 17822750 Paper 17727928 Paper 17614723 Paper 17543121 Paper 17493310 Paper 17307834 Paper 17212550 Paper 17205571 Paper 17096350 Paper 16799693 Paper 16773634 Paper 16751325 Paper 16674198 Paper 16526887 Paper 16214205 Paper 16202444 Paper 16188299 Paper 16188298 Paper 16183106 Paper 16166967 Paper 16165197 Paper 16150483 Paper 16143374 Paper 16124170 Paper 16103442 Paper 16045217 Paper 15910104 Paper 15815181 Paper 15671570 Paper 15629275 Paper 15571615 Paper 15547531 Paper 15455771 Paper 15371655 Paper 15371646 Paper 15297165 Paper 15229860 Paper 15226053 Paper 15189090 Paper 15013969 Paper 14755422 Paper 14646041 Paper 14610938 Paper 14603536 Paper 14586367 Paper 14501086

Abstract

Literature on technology assessment strongly emphasizes the need for evaluating the effect on technology and patient outcomes such as improved physical, functional, or emotional well being. This project is significant and unique because it will evaluate patient outcomes of the emerging screening and diagnostic technologies of optical spectroscopy and quantitative cytology and pathology during the developmental process. Because receiving positive Papanicoloau smear results and undergoing colposcopy and biopsy is associated with patient distress, we will focus on outcomes related to patient psychological distress and satisfaction. and satisfaction. This project is organized into four studies (A through D). Study will evaluate differences in patient pain and anxiety caused by Papanicoloau smear, colposcopically, directed biopsy, and optical spectroscopy to standard care diagnostic strategies on patient adherence, satisfaction, and quality of life. Study C will l measure the impact of false positive tests on patient well being and their intentions to adhere to future cervical cancer screening. Study D is a descriptive study of health care providers' receptivity to the innovations of optical spectroscopy and quantitative cytology, and quantitative pathology, and will be used to improve these technologies and facilitate their diffusion and implementation.

View original record on NIH RePORTER →